NYSE:CLBCore Laboratories Stock Price, Forecast & News Adding Choose a watchlist: Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Core Laboratories Please log in to your account or sign up in order to add this asset to your watchlist. Log In and Add $23.74 +1.01 (+4.44 %) (As of 08/4/2020 04:00 PM ET) Add Compare Share Today's Range$22.46Now: $23.74▼$23.9250-Day Range$19.37MA: $21.14▼$23.7452-Week Range$6.68Now: $23.74▼$52.13Volume525,750 shsAverage Volume757,572 shsMarket Capitalization$1.06 billionP/E RatioN/ADividend Yield0.18%Beta3.03 ProfileAnalyst RatingsAdvanced ChartCompetitorsDividendEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsSocial Media Core Laboratories N.V. provides reservoir description and production enhancement services and products to the oil and gas industry in the United States, Canada, and internationally. The company operates in two segments, Reservoir Description and Production Enhancement segments. The Reservoir Description segment includes the characterization of petroleum reservoir rock, fluid, and gas samples to enhance production and improve recovery of oil and gas from its clients' reservoirs. It offers laboratory-based analytical and field services to characterize properties of crude oil and petroleum products to the oil and gas industry; and proprietary and joint industry studies. The Production Enhancement segment comprises services and products relating to reservoir well completions, perforations, stimulations, and production. It offers integrated diagnostic services to evaluate and monitor the effectiveness of well completions and to develop solutions to improve the effectiveness of enhanced oil recovery projects. The company markets and sells its products through a combination of sales representatives, technical seminars, trade shows, and print advertising, as well as through distributors. Core Laboratories N.V. was founded in 1936 and is based in Amsterdam, the Netherlands.Read More Beat the Market (BTM) Rank™ 2.0 Analyst's Opinion Consensus RatingCore Laboratories has received a consensus rating of Hold. The company's average rating score is 2.07, and is based on 2 buy ratings, 11 hold ratings, and 1 sell rating.Price Target Upside/DownsideAccording to analysts' consensus price target of $26.96, Core Laboratories has a potential upside of 13.6% from its current price of $23.74.Amount of Analyst CoverageCore Laboratories has only been the subject of 4 research reports in the past 90 days. Previous Next 2.1 Community Rank Outperform VotesCore Laboratories has received 465 “outperform” votes. (Add your “outperform” vote.)Underperform VotesCore Laboratories has received 629 “underperform” votes. (Add your “underperform” vote.)Community SentimentCore Laboratories has received 57.50% “underperform” votes from our community.MarketBeat's community ratings are surveys of what our community members think about Core Laboratories and other stocks. Vote “Outperform” if you believe CLB will outperform the S&P 500 over the long term. Vote “Underperform” if you believe CLB will underperform the S&P 500 over the long term. You may vote once every thirty days. Previous Next 1.7 Dividend Strength Dividend YieldCore Laboratories has a dividend yield of 0.18%, which is in the bottom 25% of all stocks that pay dividends.Dividend GrowthCore Laboratories does not have a long track record of dividend growth.Dividend CoverageThe dividend payout ratio of Core Laboratories is 2.23%. This payout ratio is at a healthy, sustainable level, below 75%.Dividend SustainabilityBased on earnings estimates, Core Laboratories will have a dividend payout ratio of 4.65% next year. This indicates that Core Laboratories will be able to sustain or increase its dividend. Previous Next 3.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Core Laboratories insiders have bought more of their company's stock than they have sold. Specifically, they have bought $10,242.00 in company stock and sold $0.00 in company stock.Percentage Held by InsidersOnly 1.11% of the stock of Core Laboratories is held by insiders. Previous Next 0.6 Earnings and Valuation Earnings GrowthEarnings for Core Laboratories are expected to grow by 4.88% in the coming year, from $0.82 to $0.86 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Core Laboratories is -13.12, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Core Laboratories is -13.12, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Growth RatioCore Laboratories has a PEG Ratio of 9.23. PEG Ratios above 1 indicate that a company could be overvalued.Price to Book Value per Share RatioCore Laboratories has a P/B Ratio of 5.79. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities. Previous Next Analyst Opinion: 2.0Community Rank: 2.1Dividend Strength: 1.7Insider Behavior: 3.0Valuation: 0.6 5 -4 -3 -2 -1 -Overall Beat the Market Rank™1.89 out of 5 stars Industry, Sector and Symbol Stock Exchange NYSE Industry Oil & gas field services, not elsewhere classified Sub-IndustryN/A SectorOils/Energy Current SymbolNYSE:CLB Previous Symbol CUSIPN/A CIK1000229 Webwww.corelab.com Phone31-20-420-3191Debt Debt-to-Equity Ratio5.20 Current Ratio1.93 Quick Ratio1.51Price-To-Earnings Trailing P/E RatioN/A Forward P/E Ratio28.95 P/E Growth9.83 Sales & Book Value Annual Sales$668.21 million Price / Sales1.58 Cash Flow$2.41 per share Price / Cash Flow9.84 Book Value$1.49 per share Price / Book15.93Profitability EPS (Most Recent Fiscal Year)$1.79 Net Income$101.98 million Net Margins-13.39% Return on Equity46.27% Return on Assets8.41%Miscellaneous Employees4,300 Outstanding Shares44,480,000Market Cap$1.06 billion Next Earnings Date10/28/2020 (Estimated) OptionableOptionable $23.74 +1.01 (+4.44 %) (As of 08/4/2020 04:00 PM ET) 30 days | 90 days | 365 days | Advanced Chart Receive CLB News and Ratings via Email Sign-up to receive the latest news and ratings for CLB and its competitors with MarketBeat's FREE daily newsletter. Core Laboratories (NYSE:CLB) Frequently Asked Questions How has Core Laboratories' stock been impacted by COVID-19 (Coronavirus)? Core Laboratories' stock was trading at $10.93 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, CLB stock has increased by 117.2% and is now trading at $23.74. View which stocks have been most impacted by Coronavirus. Do Wall Street analysts recommend investors buy shares of Core Laboratories? 14 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Core Laboratories in the last year. There are currently 1 sell rating, 11 hold ratings and 2 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View analyst ratings for Core Laboratories. When is Core Laboratories' next earnings date? Core Laboratories is scheduled to release its next quarterly earnings announcement on Wednesday, October 28th 2020. View our earnings forecast for Core Laboratories. How were Core Laboratories' earnings last quarter? Core Laboratories (NYSE:CLB) announced its earnings results on Wednesday, July, 22nd. The oil and gas company reported $0.14 earnings per share (EPS) for the quarter, topping the Zacks' consensus estimate of $0.10 by $0.04. The oil and gas company earned $115.74 million during the quarter, compared to the consensus estimate of $115.43 million. Core Laboratories had a positive return on equity of 46.27% and a negative net margin of 13.39%. View Core Laboratories' earnings history. How often does Core Laboratories pay dividends? What is the dividend yield for Core Laboratories? Core Laboratories announced a quarterly dividend on Friday, July 17th. Stockholders of record on Monday, July 27th will be given a dividend of $0.01 per share on Monday, August 10th. This represents a $0.04 dividend on an annualized basis and a dividend yield of 0.17%. The ex-dividend date of this dividend is Friday, July 24th. View Core Laboratories' dividend history. What price target have analysts set for CLB? 14 brokerages have issued 1 year price targets for Core Laboratories' stock. Their forecasts range from $11.00 to $48.00. On average, they anticipate Core Laboratories' share price to reach $26.96 in the next year. This suggests a possible upside of 13.6% from the stock's current price. View analysts' price targets for Core Laboratories. Has Core Laboratories been receiving favorable news coverage? News stories about CLB stock have been trending somewhat negative this week, according to InfoTrie Sentiment Analysis. The research group identifies negative and positive press coverage by analyzing more than six thousand news and blog sources in real time. The firm ranks coverage of public companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Core Laboratories earned a news sentiment score of -1.0 on InfoTrie's scale. They also gave media stories about the oil and gas company a news buzz of 5.0 out of 10, indicating that recent press coverage is somewhat likely to have an impact on the company's share price in the near term. View the latest news about Core Laboratories. Are investors shorting Core Laboratories? Core Laboratories saw a decline in short interest during the month of July. As of July 15th, there was short interest totaling 5,140,000 shares, a decline of 6.0% from the June 30th total of 5,470,000 shares. Based on an average daily volume of 1,350,000 shares, the days-to-cover ratio is currently 3.8 days. Approximately 11.7% of the company's shares are short sold. View Core Laboratories' Current Options Chain. Who are some of Core Laboratories' key competitors? Some companies that are related to Core Laboratories include Subsea 7 (SUBCY), Liberty Oilfield Services (LBRT), RPC (RES), Helix Energy Solutions Group (HLX), National Energy Services Reunited (NESR), NexTier Oilfield Solutions (NEX), Propetro (PUMP), Oceaneering International (OII), Franks International (FI), Select Energy Services (WTTR), Keane Group (FRAC), North American Construction Group (NOA), Hurricane Energy (HRCXF), Key Energy Services (KEGX) and Natural Gas Services Group (NGS). View all competitors. What other stocks do shareholders of Core Laboratories own? Based on aggregate information from My MarketBeat watchlists, some companies that other Core Laboratories investors own include CA (CA), BlackRock (BLK), Chipotle Mexican Grill (CMG), Endologix (ELGX), Starbucks (SBUX), Micron Technology (MU), Gilead Sciences (GILD), Netflix (NFLX), AT&T (T) and Baidu (BIDU). Who are Core Laboratories' key executives? Core Laboratories' management team includes the following people: Mr. David M. Demshur, CEO & Chairman of Supervisory Board (Age 64)Mr. Lawrence V. Bruno, COO, Pres & Supervisory Director (Age 59)Mr. Christopher Scott Hill, Sr. VP & CFO (Age 49)Mr. Kevin G. Daniels, Chief Accounting Officer, Treasurer & VP (Age 55)Ms. Gwendolyn Y. Schreffler M.B.A., Sr. VP of Corp. Devel. & Investor Relations What is Core Laboratories' stock symbol? Core Laboratories trades on the New York Stock Exchange (NYSE) under the ticker symbol "CLB." Who are Core Laboratories' major shareholders? Core Laboratories' stock is owned by many different institutional and retail investors. Top institutional shareholders include AKO Capital LLP (2.99%), Douglas Lane & Associates LLC (0.95%), Morningstar Investment Services LLC (0.86%), First Trust Advisors LP (0.22%), Comerica Bank (0.10%) and Texas Permanent School Fund (0.08%). Company insiders that own Core Laboratories stock include Gregory Barry Barnett, Jan Willem Sodderland, Kevin Daniels, Lawrence Bruno and Mark F Elvig. View institutional ownership trends for Core Laboratories. Which major investors are selling Core Laboratories stock? CLB stock was sold by a variety of institutional investors in the last quarter, including Kopion Asset Management LLC, Texas Permanent School Fund, Raymond James Financial Services Advisors Inc., and OLD National Bancorp IN. View insider buying and selling activity for Core Laboratories. Which major investors are buying Core Laboratories stock? CLB stock was bought by a variety of institutional investors in the last quarter, including AKO Capital LLP, Morningstar Investment Services LLC, First Trust Advisors LP, Douglas Lane & Associates LLC, New York State Teachers Retirement System, Comerica Bank, Leap Investments LP, and Profund Advisors LLC. Company insiders that have bought Core Laboratories stock in the last two years include Gregory Barry Barnett, Jan Willem Sodderland, and Lawrence Bruno. View insider buying and selling activity for Core Laboratories. How do I buy shares of Core Laboratories? Shares of CLB can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. What is Core Laboratories' stock price today? One share of CLB stock can currently be purchased for approximately $23.74. How big of a company is Core Laboratories? Core Laboratories has a market capitalization of $1.06 billion and generates $668.21 million in revenue each year. The oil and gas company earns $101.98 million in net income (profit) each year or $1.79 on an earnings per share basis. Core Laboratories employs 4,300 workers across the globe. What is Core Laboratories' official website? The official website for Core Laboratories is www.corelab.com. How can I contact Core Laboratories? Core Laboratories' mailing address is STRAWINSKYLAAN 913 TOWER A LEVEL 9, AMSTERDAM P7, 1077 XX. The oil and gas company can be reached via phone at 31-20-420-3191 or via email at [email protected] This page was last updated on 8/5/2020 by MarketBeat.com Staff 30 Days of MarketBeat All Access for $1.00 Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your Risk-Free Trial Subscription Here Questions? Get Started with MarketBeat — Read Your Daily NewsletterCheck Out My MarketBeatWatch Our Tutorial VideosAdd a Stock to Your WatchlistSet Up an Instant AlertView a Company's Profile PageView Our Financial CalendarsView Today's Analyst Ratings
